TuHURA Biosciences, Inc. (HURA) Financials

HURA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 29.7 million 6.5 million
Dec. 31, 2025 27.4 million 6.4 million
Sept. 30, 2025 25.7 million 8.9 million
June 30, 2025 34.6 million 15.2 million

HURA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -4.5 million 2.8 million
Dec. 31, 2025 -5.6 million 2.0 million
Sept. 30, 2025 -11.1 million 1.6 million
June 30, 2025 -6.3 million 1.4 million

HURA Net Income

No data available :(

HURA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 6.3 million - 250075
Dec. 31, 2025 3.6 million 303627 502668
Sept. 30, 2025 2.7 million - 84346
June 30, 2025 8.5 million - 124969

HURA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 60.0 million
Dec. 31, 2025 47.9 million
Sept. 30, 2025 50.7 million
June 30, 2025 44.6 million

HURA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 48847 5.2 million 2.3 million -
Dec. 31, 2025 27850 6.1 million -1.6 million -
Sept. 30, 2025 4 5.0 million 1.8 million -
June 30, 2025 5561 4.9 million 4.9 million -

HURA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 23472
Dec. 31, 2025 - -
Sept. 30, 2025 - 21000
June 30, 2025 - -

HURA

Price: $2.23

52 week price:
0.41
3.90

Earnings Per Share: -0.61 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 139.5 million

Links: